Eculizumab

Eculizumab

Eculizumab is a recombinant humanized monoclonal antibody against the complement protein C5

 

 

[accordions]
[accordion title= “Chemical Properties“]

 

Molecular Weight 148 kDa
CAS No. 219685-50-4

 

[/accordion]

 

 

[accordions]
[accordion title= “References and Literature“]

1. Sheridan D, et al. Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action. PLoS One. 2018 Apr 12;13(4):e0195909.

[/accordion]